/
Personalis, Inc.
Personalis, Inc. develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally.
Mentions
4 mentions · latest on 1 Oct 2026
See which tracked investors hold Personalis, Inc. →Ownership and position changes on OwnershipTrace
| Investing w/ MartinBlog | September 2026 - another good month | - | 1 Oct 2026 |
| One Idea Per DayBlog | $PSNL: the stock is 17.20 and the deal is capped at 16.25 | - | 9 Sept 2026 |
| Investing w/ MartinBlog | August Wrap Up | - | 2 Sept 2026 |
| Investing w/ MartinBlog | July Results | - | 3 Aug 2026 |